The Cancer Genomics group is also working on identifying somatic mutations involved in the mechanisms of sensitivity or resistance to PI3K inhibitors in breast cancers and gliomas. It is working in close collaboration with basic and clinical researchers from the genomics service in Vall d'Hebron Institute of Oncology. Visit the research group’s page Centres General Hospital Children's Hospital and Woman's Hospital Vall d'Hebron Institute of Oncology Serveis Medical Oncology Paediatric Oncology and Haematology Ponderació 9 Recerca Grup de genòmica del càncer Enllaç http://www.vhio.net/research/core-technologies/cancer-genomics-group/index.php